pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Intron A
drug
save

interferon alfa-2b

Marketedupdated 3mo ago
by Schering-Plough Corp (Inactive)
Approved
community read0 votes

indications

investigational
MelanomaDLBCL

all catalysts(0)

nothing on the calendar yet

Trials studying interferon alfa-2b

  • phase3A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025)not yet recruitingn=380
  • phase3Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intoleranceactive not recruitingn=174
  • phase2Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgeryactive not recruitingn=12
  • phase1Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)recruitingn=38
  • phase2Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemianot yet recruitingn=35
  • phase2Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patientsterminatedn=4
  • phase3Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapycompletedn=109
  • phase3Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected Patientscompletedn=108
more trials →

News(0)

no news has mentioned this drug yet

brand
Intron A
generic
interferon alfa-2b
indication
Genital Warts (Condylomata Acuminata)
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 40m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?